These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 2994554)
1. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554 [TBL] [Abstract][Full Text] [Related]
2. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Joyce JN; Lexow N; Bird E; Winokur A Synapse; 1988; 2(5):546-57. PubMed ID: 2973147 [TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia. Palacios JM; Chinaglia G; Rigo M; Ulrich J; Probst A Synapse; 1991 Feb; 7(2):114-22. PubMed ID: 1672780 [TBL] [Abstract][Full Text] [Related]
4. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947 [TBL] [Abstract][Full Text] [Related]
5. Huntington's chorea. Changes in neurotransmitter receptors in the brain. Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733 [TBL] [Abstract][Full Text] [Related]
6. Brain neurotransmitter receptor alterations in offspring of rats exposed to phenobarbital, phenytoin or their combination during pregnancy. Seth PK; Alleva FR; Takagi S; Yen-Koo HC; Balazs T Neurotoxicology; 1987; 8(1):45-53. PubMed ID: 3031564 [TBL] [Abstract][Full Text] [Related]
7. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. MartÃnez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088 [TBL] [Abstract][Full Text] [Related]
8. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats. Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease. Allen KL; Waldvogel HJ; Glass M; Faull RL J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011 [TBL] [Abstract][Full Text] [Related]
10. Quantitative autoradiography of neurotransmitter receptors in Huntington disease. Penney JB; Young AB Neurology; 1982 Dec; 32(12):1391-5. PubMed ID: 6292789 [TBL] [Abstract][Full Text] [Related]
11. Acute pentylenetetrazol injection reduces rat GABAA receptor mRNA levels and GABA stimulation of benzodiazepine binding with No effect on benzodiazepine binding site density. Walsh LA; Li M; Zhao TJ; Chiu TH; Rosenberg HC J Pharmacol Exp Ther; 1999 Jun; 289(3):1626-33. PubMed ID: 10336561 [TBL] [Abstract][Full Text] [Related]
12. Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients. Ahlskog JE; Richelson E; Nelson A; Kelly PJ; Okazaki H; Tyce GM; van Heerden JA; Stoddard SL; Carmichael SW Ann Neurol; 1991 Aug; 30(2):185-91. PubMed ID: 1654766 [TBL] [Abstract][Full Text] [Related]
13. Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain. Bonaventure P; Hall H; Gommeren W; Cras P; Langlois X; Jurzak M; Leysen JE Synapse; 2000 Apr; 36(1):35-46. PubMed ID: 10700024 [TBL] [Abstract][Full Text] [Related]
14. NMDA receptor losses in putamen from patients with Huntington's disease. Young AB; Greenamyre JT; Hollingsworth Z; Albin R; D'Amato C; Shoulson I; Penney JB Science; 1988 Aug; 241(4868):981-3. PubMed ID: 2841762 [TBL] [Abstract][Full Text] [Related]
15. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Glass M; Dragunow M; Faull RL Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533 [TBL] [Abstract][Full Text] [Related]
16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Suzuki M; Desmond TJ; Albin RL; Frey KA Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403 [TBL] [Abstract][Full Text] [Related]
17. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. London ED; Yamamura HI; Bird ED; Coyle JT Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910 [TBL] [Abstract][Full Text] [Related]